Rosen Law Firm, a global investor rights firm, reminds purchasers of TriNet Group, Inc. (NYSE:TNET) securities from May 5, 2014 through August 3, 2015 of the important October 6, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover investors’ losses under the federal securities laws.

To join the TriNet Group class action, visit the firm’s website at http://www.rosenlegal.com/cases-692.html, or contact Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY CHOOSE TO DO NOTHING AT THIS POINT AND REMAIN AN ABSENT CLASS MEMBER.

According to the lawsuit, Defendants issued materially false and misleading statements and/or omitted material information, including that: (a) TriNet’s procedures and techniques for analyzing and accruing claims failed to properly account for historical claims trends; (b) TriNet’s predicting procedure failed to properly incorporate relevant historical and current claims trends; and (c) TriNet underwent increasing claims trends in medical and workers compensation that adversely affected TriNet’s current and future business prospects. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than October 6, 2015. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://www.rosenlegal.com/cases-692.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll-free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.